Madigan Catherine bought COAG
April 30, 2026 · Form 4 insider transaction
Madigan Catherine bought 49,016 shares of Hemab Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
49,016
Price
$0.00
Total value
N/A
InsiderMadigan Catherine
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 30, 2026
Filing dateMay 4, 2026
Shares owned after49,016
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on April 30, 2026. The shares underlying the option will vest over four years in equal monthly installments from May 1, 2026 through May 1, 2030.